Medplus Health Services Limited (MEDPLUS) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Medplus Health Services Limited stock ₹708, price ₹619, upside +14.4%, quality 59 out of 100. Rating: undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Medplus Health Services Limited
MEDPLUS · NSESolid company, but only slightly cheap (13% below fair value) and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
59‑month range ₹576.30 – ₹1,290 · fair‑value band ₹518.24 – ₹919.98 · the ₹618.60 price screens below the ₹707.67 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.
Every Wednesday you see whether Medplus Health Services is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India.
Show moreShow less
It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers.
The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres.
It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
Stock analysis
Medplus Health Services Limited (MEDPLUS) currently trades at ₹618.60, while our model-based Fair Value estimate is ₹707.67, implying the stock looks roughly 13% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹626.34 per share, and 6 of the 24 models we run sit above the ₹618.60 price.
Bear case: the Economic Profit group reads lowest at ₹202.62, and 18 of the 24 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹518.24 (bear) to ₹919.98 (bull), the price of ₹618.60 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Medplus Health Services Limited reported revenue of ₹68.9B in FY2026 versus ₹37.8B in FY2022, a compound +16.2%/yr. Reported net income was ₹2.2B in FY2026, compounding +23.1%/yr from FY2022.
Key figures
Market cap ₹74.3B (≈ $788M) Small · P/E ratio 35.1 · P/S ratio 0.98 · EPS (TTM) ₹17.62 · Net margin 2.8% · Return on equity 10.8% · Return on assets (EBIT) 15.7% (5-year average) · Operating margin 5.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (medium confidence).
What moves the price
The share trades about 35% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 23% fair-value upside, at 14%, MEDPLUS screens richer than that median.
Fair Value models
All 24 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch MEDPLUS, get fair value alerts →
Compare Medplus Health Services Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 52 stocks
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Al-Dawaa Medical Services Company 4163 | 38.64 SAR | 79.49 SAR | +106% | vs MEDPLUS |
| JD Health International Inc 6618 | HK$41.28 | HK$75.64 | +83% | vs MEDPLUS |
| Yifeng Pharmacy Chain Co 603939 | ¥26.17 | ¥40.59 | +55% | vs MEDPLUS |
| Yixintang Pharmaceutical Group 002727 | ¥13.36 | ¥18.92 | +42% | vs MEDPLUS |
| DaShenLin Pharmaceutical Group 603233 | ¥20.79 | ¥25.52 | +23% | vs MEDPLUS |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥13.15 | ¥14.66 | +12% | vs MEDPLUS |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥14.81 | ¥15.66 | +6% | vs MEDPLUS |
| DocMorris AG DOCM | CHF 18.08 | CHF 15.17 | −16% | vs MEDPLUS |
| ShuYu Civilian Pharmacy Corp 301017 | ¥13.25 | ¥5.91 | −55% | vs MEDPLUS |
| Apotea AB APOTEA | kr 101.80 | kr 39.50 | −61% | vs MEDPLUS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Medplus Health Services Limited (MEDPLUS) overvalued or undervalued?
What is the fair value of MEDPLUS?
What is the quality score of MEDPLUS?
What is the price target for Medplus Health Services Limited (MEDPLUS)?
What is the Medplus Health Services Limited stock forecast for 2026?
What is the revenue of Medplus Health Services Limited (MEDPLUS)?
What growth is priced into Medplus Health Services Limited (MEDPLUS)?
What discount rate (WACC) does the fair value of MEDPLUS use?
What is a reverse DCF?
How much growth has Medplus Health Services Limited (MEDPLUS) delivered so far?
How fast is the sector of Medplus Health Services Limited (MEDPLUS) growing?
What is the free cash flow yield of Medplus Health Services Limited (MEDPLUS)?
What is the intrinsic value of Medplus Health Services Limited (MEDPLUS)?
Is Medplus Health Services Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MEDPLUS?
How much is Medplus Health Services Limited worth?
What do the bullish and bearish scenarios say about MEDPLUS?
What is the P/E ratio of MEDPLUS?
How solid is the balance sheet of Medplus Health Services Limited (MEDPLUS)?
How far is MEDPLUS from its 52-week high?
Which stocks are comparable to Medplus Health Services Limited?
Is Medplus Health Services Limited stock attractive at the current price?
How is the fair value of MEDPLUS calculated?
Is it still worth investing in stocks now?
What is the share price of Medplus Health Services Limited (MEDPLUS)?
What should I pay attention to with Medplus Health Services Limited right now?
Key figures of Medplus Health Services Limited
How large is the market capitalisation of Medplus Health Services Limited (MEDPLUS)?
What is the P/S ratio of Medplus Health Services Limited (MEDPLUS)?
What are the earnings per share of Medplus Health Services Limited (MEDPLUS)?
What is the net margin of Medplus Health Services Limited (MEDPLUS)?
What is the return on equity of Medplus Health Services Limited (MEDPLUS)?
What is the EBIT return on assets of Medplus Health Services Limited (MEDPLUS)?
What is the operating margin of Medplus Health Services Limited (MEDPLUS)?
How fast is revenue growing at Medplus Health Services Limited (MEDPLUS)?
How fast are earnings growing at Medplus Health Services Limited (MEDPLUS)?
How much net debt does Medplus Health Services Limited (MEDPLUS) carry?
Watch Medplus Health Services Limited in the live analysis
One click puts Medplus Health Services Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.